H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| Alkermes, Inc. | 3 | $186,000 | $186,000 - $202,000 | 100.0% |
| MANNKIND CORPORATION | 2 | $178,750 | $170,000 - $187,500 | 100.0% |
| SAGE THERAPEUTICS | 2 | $139,931 | $139,931 - $139,931 | 100.0% |
| Sangamo Therapeutics, Inc. | 2 | $211,349 | $211,349 - $211,349 | 50.0% |
| Regeneron Pharmaceuticals, Inc. | 2 | $166,000 | $112,000 - $220,000 | 100.0% |
| AUTOLUS INC. | 1 | $185,000 | $185,000 - $185,000 | 100.0% |
| ALLOGENE THERAPEUTICS | 1 | $176,879 | $176,879 - $176,879 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Director | 12 | $186,000 | $139,931 - $220,000 |
| Manager | 1 | $112,000 | $112,000 - $112,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Waltham | MA | 3 | $186,000 |
| Cambridge | MA | 3 | $139,931 |
| Richmond | CA | 2 | $211,349 |
| Danbury | CT | 2 | $178,750 |
| Rockville | MD | 1 | $185,000 |
| South San Francisco | CA | 1 | $176,879 |
| Rensselaer | NY | 1 | $112,000 |
These roles are variations of Associate Director, CMC Regulatory Affairs with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Associate Director, CMC Regulatory Affairs | 12 | $184,662 | |
| Associate Manager, CMC Regulatory Affairs | 1 | $112,000 | |
| Senior Associate of CMC, Regulatory Affairs | 1 | $67,434 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 3 | $139,931 | 100.0% |
| 2022 | 3 | $211,349 | 66.7% |
| 2023 | 1 | $170,000 | 100.0% |
| 2024 | 1 | $185,000 | 100.0% |
| 2025 | 1 | $220,000 | 100.0% |
| 2026 | 4 | $186,750 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| Alkermes, Inc. | 3 | $186,000 | 100.0% |
| MANNKIND CORPORATION | 2 | $178,750 | 100.0% |
| SAGE THERAPEUTICS | 2 | $139,931 | 100.0% |
| Sangamo Therapeutics, Inc. | 2 | $211,349 | 50.0% |
| Regeneron Pharmaceuticals, Inc. | 2 | $166,000 | 100.0% |